Too-Low Iron Doses and Too Many Dropouts in Negative Iron Trial?

被引：13

作者：

Aapro, Matti ^{[1
]}

Beguin, Yves ^{[2
,3
]}

Birgegard, Gunnar ^{[4
]}

Gascon, Pere ^{[5
]}

Hedenus, Michael ^{[6
]}

Osterborg, Anders ^{[7
,8
]}

机构：

[1] Inst Multidisciplinaire Oncol, Clin Genolier, Genolier, Switzerland

[2] Ctr Hosp Univ Liege, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Uppsala Univ, Uppsala, Sweden

[5] Hosp Clin Barcelona, Barcelona, Spain

[6] Sundsvall Hosp, Sundsvall, Sweden

[7] Karolinska Inst, Stockholm, Sweden

[8] Karolinska Hosp, S-10401 Stockholm, Sweden

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 17期

关键词：

CHEMOTHERAPY-RELATED ANEMIA; EVERY; 3; WEEKS; INTRAVENOUS IRON; ALPHA; MULTICENTER;

D O I：

10.1200/JCO.2011.35.3219

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：E525 / E526

页数：2

相关论文

共 14 条

[1] Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial [J].

Auerbach, M ;

Ballard, H ;

Trout, JR ;

McIlwain, M ;

Ackerman, A ;

Bahrain, H ;

Balan, S ;

Barker, L ;

Rana, J .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1301-1307

[2]

Auerbach M, 2010, INTRAVENOUS IRON FAI

[3] Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia [J].

Auerbach, Michael ;

Silberstein, Peter T. ;

Webb, R. Timothy ;

Averyanova, Svetlana ;

Ciuleanu, Tudor-Eliade ;

Shao, James ;

Bridges, Kenneth .

AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (09) :655-663

[4] Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia [J].

Bastit, Laurent ;

Vandebroek, An ;

Altintas, Sevilay ;

Gaede, Bernd ;

Pinter, Tamas ;

Suto, Tamas S. ;

Mossman, Tony W. ;

Smith, Kay E. ;

Vansteenkiste, Johan F. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1611-1618

[5]

Beguin Y, 2008, BLOOD, V112, P27

[6]

Bellet RE, 2007, J CLIN ONCOL, V25

[7]

Gafter-Gvili A, 2010, BLOOD, V116, P21

[8] Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies:: a randomized multicenter study [J].

Hedenus, M. ;

Birgegard, G. ;

Nasman, P. ;

Ahlberg, L. ;

Karlsson, T. ;

Lauri, B. ;

Lundin, J. ;

Larfars, G. ;

Osterborg, A. .

LEUKEMIA, 2007, 21 (04) :627-632

[9] Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy [J].

Henry, David H. ;

Dahl, Naomi V. ;

Auerbach, Michael ;

Tchekmedyian, Simon ;

Laufman, Leslie R. .

ONCOLOGIST, 2007, 12 (02) :231-242

[10]

Mhaskar R, 2010, BLOOD, V116, P21